Clinical Trial

A First-in-Human Single and Multiple Ascending Dose Study of MT-201

Name: A First-in-Human Single and Multiple Ascending Dose Study of MT-201 — clinical trial record (NCT07219368)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

First-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single and multiple doses of MT-201 in healthy participants.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-10-17.

Trial Details

NCT Number	NCT07219368
Lead Sponsor	Mirador Therapeutics, Inc.
Conditions	Healthy Volunteer
Enrollment	72 participants
Start Date	2025-10-08
Primary Completion	2026-11-24 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-11-04